1-61081954-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_001145512.2(NFIA):c.11G>A(p.Cys4Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000572 in 1,398,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001145512.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFIA | NM_001145512.2 | c.11G>A | p.Cys4Tyr | missense_variant | 1/12 | NP_001138984.1 | ||
NFIA | NM_001145511.2 | c.3+4326G>A | intron_variant | NP_001138983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFIA | ENST00000371189.8 | c.11G>A | p.Cys4Tyr | missense_variant | 1/12 | 2 | ENSP00000360231 | |||
NFIA | ENST00000371191.5 | c.97-6195G>A | intron_variant | 5 | ENSP00000360233 | |||||
NFIA | ENST00000407417.7 | c.3+4326G>A | intron_variant | 2 | ENSP00000384680 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000659 AC: 1AN: 151654Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 81034
GnomAD4 exome AF: 0.00000572 AC: 8AN: 1398296Hom.: 0 Cov.: 32 AF XY: 0.00000435 AC XY: 3AN XY: 689732
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.11G>A (p.C4Y) alteration is located in exon 1 (coding exon 1) of the NFIA gene. This alteration results from a G to A substitution at nucleotide position 11, causing the cysteine (C) at amino acid position 4 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at